A 3D printed human upper respiratory tract model for particulate deposition profiling

A novel approach to investigate severe asthma and COPD: the 3d ex vivo respiratory mucosa model

Purpose: This article illustrates the replication of asthma and COPD conditions in a laboratory setting and the potential applications of this methodology.

Introduction: Biologic drugs have been shown to enhance the treatment of severe asthma and COPD. Monoclonal antibodies against specific targets have dramatically changed the management of these conditions. Although the inflammatory pathways of asthma and COPD have already been clearly outlined, alternative mechanisms of action remain mostly unexplored. They could provide additional insights into these diseases and their clinical management.

Aims: In vivo or in vitro models have thus been developed to test alternative hypotheses. This study describes sophisticated ex vivo models that mimic the response of human respiratory mucosa to disease triggers, aiming to narrow the gap between laboratory studies and clinical practice.

Results: These models successfully replicate crucial aspects of these diseases, such as inflammatory cell presence, cytokine production, and changes in tissue structure, offering a dynamic platform for investigating disease processes and evaluating potential treatments, such as monoclonal antibodies. The proposed models have the potential to enhance personalized medicine approaches and patient-specific treatments, helping to advance the understanding and management of respiratory diseases.

The Role of Biophysical Factors in Organ Development: Insights from Current Organoid Models

Biophysical factors play a fundamental role in human embryonic development. Traditional in vitro models of organogenesis focused on the biochemical environment and did not consider the effects of mechanical forces on developing tissue. While most human tissue has a Young's modulus in the low kilopascal range, the standard cell culture substrate, plasma-treated polystyrene, has a Young's modulus of 3 gigapascals, making it 10,000-100,000 times stiffer than native tissues. Modern in vitro approaches attempt to recapitulate the biophysical niche of native organs and have yielded more clinically relevant models of human tissues. Since Clevers' conception of intestinal organoids in 2009, the field has expanded rapidly, generating stem-cell derived structures, which are transcriptionally similar to fetal tissues, for nearly every organ system in the human body. For this reason, we conjecture that organoids will make their first clinical impact in fetal regenerative medicine as the structures generated ex vivo will better match native fetal tissues. Moreover, autologously sourced transplanted tissues would be able to grow with the developing embryo in a dynamic, fetal environment. As organoid technologies evolve, the resultant tissues will approach the structure and function of adult human organs and may help bridge the gap between preclinical drug candidates and clinically approved therapeutics. In this review, we discuss roles of tissue stiffness, viscoelasticity, and shear forces in organ formation and disease development, suggesting that these physical parameters should be further integrated into organoid models to improve their physiological relevance and therapeutic applicability. It also points to the mechanotransductive Hippo-YAP/TAZ signaling pathway as a key player in the interplay between extracellular matrix stiffness, cellular mechanics, and biochemical pathways. We conclude by highlighting how frontiers in physics can be applied to biology, for example, how quantum entanglement may be applied to better predict spontaneous DNA mutations. In the future, contemporary physical theories may be leveraged to better understand seemingly stochastic events during organogenesis.

Fibres in the nasal cavity: A pilot study of the recovery, background, and transfer in smothering scenarios

In cases where the suspected cause of death is smothering, fibre traces recovered from the nasal cavity are hypothesised to refute or support this proposition. In order to carry out such evaluations, an efficient recovery method must first be established. This pilot study tested five different recovery methods on 3D printed models of nasal cavities. Among which, the use of the transparent AccuTrans® polyvinyl Siloxane casts demonstrated the best recovery efficiency with a median of 90% of deposited fibres recovered. The efficacy of this method was then verified on cadavers. Apart from a reliable recovery method, an understanding of the background population of fibres in nasal cavities, as well as the mechanisms of the transfer from the purported smothering textile to the nasal cavity is essential to evaluate the findings in these cases of suspected smothering. Samplings of the nasal cavities of 20 cadavers were thus carried out to gather data on the background population of fibres. Results showed that nasal cavities are not void of fibres, but the quantities are expected to be low, with a mean of 3.8 fibres per cavity recovered. Information on generic fibre class, colour, and length of these background fibres were also obtained with the use of low and high-power microscopy. The frequencies found in this population of fibres closely align with data from other population studies where black cotton was the most common. Finally, transfer experiments using the 3D printed models fitted with a respiratory pump to simulate breathing were carried out, along with testing on live volunteers in-vivo. The results demonstrated a verifiable transfer of fibres into the nasal cavity in smothering scenarios. Textiles of various shedding capacities were used in these tests and the findings suggest an influence of this variable on the quantities of fibres transferred.

The impact of actuator nozzle and surroundings condition on drug delivery using pressurized-metered dose inhalers

The most commonly used method to deliver aerosolized drugs to the lung is with pressurized metered-dose inhalers (pMDIs). The spray actuator is a critical component of pMDI, since it controls the atomization process by forming aerosol plumes and determining droplet size distribution. Through computational fluid dynamics (CFD) simulations, this study investigated the effect of two different nozzle types (single conventional and twin nozzles) on drug deposition in the mouth-throat (MT) region. We also studied the behavior of aerosol plumes in both an open-air environment and the MT geometry. Our study revealed that spray aerosol generated in an unconfined, open-air environment with no airflow behaves distinctly from spray introduced into the MT geometry in the presence of airflow. In addition, the actuator structure significantly impacts the device's efficacy. In the real MT model, we found that the twin nozzle increases drug deposition in the MT region, and its higher aerosol velocity negatively affects its efficiency.

Effects of vocal fold adduction on the particle deposition in the glottis: A numerical analysis and in vitro assessment

BACKGROUND

The efficacy of inhalation therapy depends on the drug deposition in the human respiratory tract. This study investigates the effects of vocal fold adduction on the particle deposition in the glottis.

METHODS

A realistic mouth-throat (MT) geometry was built based on CT images of a healthy adult (MT-A). Mild (MT-B) and great (MT-C) vocal fold (VF) adduction were incorporated in the original model. Monodisperse particles range in size from 3 to 12 μm were simulated at inspiration flow rates of 15, 30 and 45 L per minute (LPM). The regional deposition of drug aerosols was performed in 3D-printed models and quantified using high-performance liquid chromatography.

RESULTS

Both the numerical analysis and in vitro experiments show that most particles are deposited in the mouth, pharynx and supraglottis, while few are deposited in the glottis and subglottis. For most cases in MT-A, the particle quantity in glottis is lower than 0.02 N/mm2 at 15 and 30 LPM while they increase dramatically at 45 LPM. It peaked at 0.347 N/mm2 for 5-μm particles at 45 LPM in MT-B and 2.324 N/mm2 for 6-μm particles at 30 LPM in MT-C. The lowest drug mass faction in the glottis in vitro were found at 15 LPM for MT-A and MT-C, and at 30 LPM for MT-B, whereas it peaked at 45 LPM for all MT models, 0.71% in MT-A, 1.16% in MT-B, and 2.53% in MT-C, respectively.

CONCLUSION

Based on the results of this study, larger particles are more likely to be deposited in the oral cavity, oropharynx, and supraglottis than in the glottis. However, particle deposition in the glottis generally increases with VF adduction and greater inspiratory flow rates.

Study on the coal dust deposition fraction and site in the upper respiratory tract under different particle sizes and labor intensities

In order to study the dust exposure amount and coal dust deposition rule of coal miners under different labor intensity in coal mine environment, an airflow-particle two-phase coupling calculation model of human upper respiratory tract was established based on Euler-Lagrange framework, and the airflow field in the upper respiratory tract and the characteristics of coal dust deposition were simulated and studied. By comparing the experimental data, the relative error of simulation is in the range of 1.5 %-11.2 %. The results showed that the total deposition fraction of 1 μm dust was the smallest (0.61-1.20 %), and was relatively less affected by respiratory intensity, and the overall distribution was uniform. When the dust particle size increased to 7.07 μm, the total dust deposition fraction in the nasal cavity, pharynx and larynx was in the range of 11.10 %-20.91 %, and increased with the respiratory intensity. When the dust particle size was large, the dust particles of 20 μm and 80 μm were mostly concentrated in the front of the nasal cavity, and the deposition amount of 80 μm dust was about 99.52 %. It was found that with the increase of dust particle size or the increase of labor intensity, the possibility of dust being transported into lungs became smaller. The fitting function of 7.07 μm dust escape rate and labor intensity was obtained, for example, Y_7.07μm = 91.73-0.22n (n is labor intensity), and the escape rate of dust with 7.07 μm particle size was up to 88.90 %. Most of them escape from the upper respiratory tract and enter the lungs, which provides theoretical guidance for quantifying the accumulated dust exposure amount in the lungs and monitoring respiratory dust concentration.

Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research

The emergence of novel respiratory infections (e.g., COVID-19) and expeditious development of nanoparticle-based COVID-19 vaccines have recently reignited considerable interest in designing inhalable nanoparticle-based drug delivery systems as next-generation respiratory therapeutics. Among various available devices in aerosol delivery, dry powder inhalers (DPIs) are preferable for delivery of nanoparticles due to their simplicity of use, high portability, and superior long-term stability. Despite research efforts devoted to developing inhaled nanoparticle-based DPI formulations, no such formulations have been approved to date, implying a research gap between bench and bedside. This review aims to address this gap by highlighting important yet often overlooked issues during pre-clinical development. We start with an overview and update on formulation and particle engineering strategies for fabricating inhalable nanoparticle-based dry powder formulations. An important but neglected aspect in in vitro characterization methodologies for linking the powder performance with their bio-fate is then discussed. Finally, the major challenges and strategies in their clinical translation are highlighted. We anticipate that focused research onto the existing knowledge gaps presented in this review would accelerate clinical applications of inhalable nanoparticle-based dry powders from a far-fetched fantasy to a reality.